Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 20c; Bumps Guidance Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Zimmer Biomet Announces First Quarter 2022 Financial Results
May 3, 2022 6:30 AM EDTFirst quarter net sales from continuing operations of $1.663 billion increased 3.9% and 6.8% on a constant currency1 basis First quarter diluted earnings per share from continuing operations were $0.35; adjusted1 diluted earnings per share from continuing operations were $1.61 Company updates 2022 financial guidance, raising and tightening range for full year outlook Completed the spinoff of ZimVie Inc. on March 1, 2022
WARSAW, Ind., May 3, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2022. The Company reported first quarter net sales from continuing operations of... More
